By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Spero Therapeutics 

400 Technology Square, 10th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a


Key Statistics

Ownership: Private

Web Site: Spero


Company News
Spero Announces Appointment Of Frank Thomas To Its Board Of Directors And Promotions Within Leadership Team 9/6/2017 10:11:31 AM
Spero Appoints Joel Sendek As Chief Financial Officer 5/22/2017 6:55:44 AM
Spero Receives Grant From NIH To Explore Novel Treatment Combinations For Tuberculosis 5/4/2017 7:12:07 AM
Spero Receives $6.8 Million Award From CARB-X To Combat Antibiotic-Resistant Bacteria 3/30/2017 8:28:16 AM
Backed by Google (GOOG), Cambridge's Spero Nabs $51.7 Million Series C 3/8/2017 6:44:58 AM
Spero Acquires Next Generation Antibacterial Candidates From Pro Bono Bio For Treatment Of Multidrug-Resistant, Gram-Negative Infections 1/31/2017 6:47:24 AM
Spero Initiates First Clinical Study Of Lead Potentiator Candidate For The Treatment Of Multidrug Resistant Gram-Negative Infections 12/19/2016 9:43:15 AM
Spero Announces $1.65 Million Award From Department Of Defense To Develop Novel Combination Therapy For Multidrug-Resistant, Gram-Negative Pathogens 10/18/2016 11:55:52 AM
Spero To Participate In Citi's 11th Annual Biotech Conference 9/6/2016 1:39:28 PM
Spero Joins ENABLE (European Gram-Negative Antibacterial Engine) Project To Combat Antibiotic-Resistant Bacteria 9/6/2016 9:49:18 AM